DAVITA INC. (DVA) FY2026 Q3 P&L / Income Statement

Published · Updated Source: Form 10-Q on SEC EDGAR filed (opens in a new tab)

Key Takeaways

  • Other operating segments grew sales 22% to $549.66 M, yet swung to an $18.64 M operating loss.
  • Management's adjusted measure puts these businesses' operating income at $44 million, not a loss.
  • U.S. dialysis kept 18% of its $3.03 B in sales as operating income this quarter.
  • Combined segment margin fell 0.8 points from a year earlier, to 14.7% of sales.

The Unvarnished Truth

DaVita's fastest-growing business swung to an $18.64 M quarterly loss

DaVita's smaller business line grew fastest and lost money. Its other operating segments lifted sales 22% to $549.66 M, yet posted an $18.64 M operating loss against a $1.22 M profit a year earlier. These segments are mainly integrated kidney care and the international clinics. The culprit is the $62.18 M write-down of the business in China. Strip it out and management's adjusted operating income for these businesses was $44 million. So the loss stems from the charge, but that charge is a warning about what the expansion abroad is worth.

Why did the core not offset it? U.S. dialysis, 85% of sales, grew just 2.0% and earned $544.18 M of operating income, against $530.11 M a year earlier. That is a margin of 18%, steady but not spectacular. Together the segments earned $525.54 M before head-office costs, down from $531.33 M. Their blended margin slipped 0.8 points, to 14.7%. Head-office costs and other items then trimmed the total to $499.26 M of operating income. The growth engine, in other words, is the business that just took the write-down.

For investors the split is a warning. Dialysis grows slowly and profitably; the faster-growing segments are where DaVita is placing its bets, and they are where value just evaporated. Management blames adverse reimbursement rate changes in non-renal hospital services in China, and the goodwill note says the unit remains at risk. Watch the adjusted operating income of the international clinics and whether these segments can turn growth into profit without further write-downs. If these segments keep growing fast while losing money on paper, are they building value or burning it?

Revenue by Business Segment (2 categories)

Swipe to see the full flow
DAVITA INC. (DVA) FY2026 Q3 P&L / Income StatementIncome statement for 2026-07-01 through 2026-09-30. View: Business segment (2 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.SOURCESREVENUEOPERATINGPRE-TAXNETU. S. Dialysis And Related Lab ServicesOther Operating SegmentTotal revenuesOperating incomeTotal operating expensesPatient care costsGeneral and administrativeDepreciation and amortizationEquity investment income, netGoodwill and other asset impairment chargesIncome before income taxesOther income (expense), net (calculated)Net incomeIncome tax expenseTotal revenuesTotal revenues$3.58 BOperating incomeOperating income$499.26 MIncome before income taxesPretax income$358.71 MNet incomeNet income$269.39 MTotal operating expensesTotal operatingexpenses$3.08 BIncome tax expenseIncome tax expense$89.32 MU. S. Dialysis And Related Lab ServicesU. S. Dialysis AndRelated Lab Services$3.03 BOther income (expense), net (calculated)Other income,net (calculated)−$140.55 MPatient care costsPatient care costs$2.45 BOther Operating SegmentOther Operating Segment$549.66 MGeneral and administrativeGeneral and administrative$408.70 MDepreciation and amortizationDepreciation and amortization$165.19 MEquity investment income, netEquity investment income, net−$8.24 MGoodwill and other asset impairment chargesGoodwill and other assetimpairment charges$62.18 M
Chart details

DAVITA INC. (DVA) FY2026 Q3 P&L / Income Statement

Income statement for 2026-07-01 through 2026-09-30. View: Business segment (2 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenues
3,578,126,000 US dollars
Total operating expenses
3,078,871,000 US dollars
Operating income
499,255,000 US dollars
Other income (expense), net (calculated)
negative 140,548,000 US dollars
Income before income taxes
358,707,000 US dollars
Income tax expense
89,318,000 US dollars
Net income
269,389,000 US dollars
U. S. Dialysis And Related Lab Services
3,028,470,000 US dollars
Other Operating Segment
549,656,000 US dollars
Patient care costs
2,451,047,000 US dollars
General and administrative
408,697,000 US dollars
Depreciation and amortization
165,188,000 US dollars
Equity investment income, net
negative 8,237,000 US dollars
Goodwill and other asset impairment charges
62,176,000 US dollars

Chart connections

  • Revenue minus operating expenses equals operating income.
  • Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
  • Of which attributable to DAVITA INC.: $222.93 M; to noncontrolling interests: $46.46 M.
DAVITA INC. (DVA) FY2026 Q3 Revenue by Business Segment (2 categories) Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Intelligent Insights for Investors

How profitable is each of DaVita's businesses?

U.S. dialysis is the most profitable: it kept 18% of its sales as operating income this quarter. The other operating segments posted a loss equal to 3.4% of their sales.

Which of DaVita's businesses drove its profit change over the past year?

The other operating segments alone: their result fell by $19.86 M from a year earlier, more than the segments' combined operating profit fell overall, because U.S. dialysis moved the other way.

How much do head-office costs take out of DaVita's business profits?

Its businesses earned $525.54 M of operating income this quarter. After head-office costs and other items kept outside them, $499.26 M was left.

Intelligent Insights for Employees

Is any of DaVita's businesses losing money?

Yes: the other operating segments lost $18.64 M this quarter on their operating income measure, equal to 3.4% of their sales.

Intelligent Insights for Everyone

Which of DaVita's businesses brings in the most sales?

U.S. dialysis and related lab services carries the sales, with 85% this quarter. Next come the other operating segments, at 15%.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!